Clinical Trials Logo

Filter by:
NCT ID: NCT04224857 Completed - Ulcerative Colitis Clinical Trials

SAD/MAD Study in Healthy Subjects and Adults With UC to Evaluate Safety, Tolerability, PK, PD of AMT-101

AURIGA1
Start date: April 1, 2019
Phase: Phase 1
Study type: Interventional

A randomized, double-blind placebo-controlled first in human study in approximately 36 male healthy subjects and approximately 20 male and female patients with active UC who have had an inadequate response to or demonstrated intolerance to 5-ASA.

NCT ID: NCT04223843 Completed - Clinical trials for Pulmonary Disease, Chronic Obstructive

A Study to Test the Combination of Tiotropium and Olodaterol Using the Respimat® Inhaler in People With Chronic Obstructive Pulmonary Disease (COPD) Who Have Different Abilities to Inhale

Start date: January 8, 2020
Phase: Phase 4
Study type: Interventional

To demonstrate the efficacy of inhaled tiotropium + olodaterol via Respimat® on lung function in patients with moderate to severe Chronic Obstructive Pulmonary Disease (COPD) with optimal and sub-optimal Peak Inspiratory Flow Rate (PIFR). Disease severity (moderate to severe) is based on the Global Initiative for Chronic Lung Disease (GOLD) guidelines (GOLD 2 - 3)

NCT ID: NCT04222647 Completed - Clinical trials for Vulvovaginal Atrophy

Investigation of Efficacy and Tolerability of a Lactic Acid Containing Vaginal Suppository in Post-menopausal Women With VVA

Start date: January 27, 2020
Phase: Phase 2
Study type: Interventional

The aim of the study is to investigate the efficacy and tolerability of a lactic acid containing vaginal suppository with respect to the application in post-menopausal women with VVA.

NCT ID: NCT04221906 Completed - Clinical trials for Chronic Plaque Psoriasis

Study to Evaluate the Safety and Antipsoriatic Efficacy of BOS-475 in a Psoriasis Plaque Test

Start date: January 6, 2020
Phase: Phase 1
Study type: Interventional

This study is being conducted to evaluate the safety of topical BOS-475 compared to topically applied comparator formulations and vehicle.

NCT ID: NCT04219215 Completed - Type 2-diabetes Clinical Trials

Acute Hyperbaric Oxygen Treatment Increases Hepatic Insulin Sensitivity and Muscle Reactive Oxygen Species in T2D

Start date: February 1, 2020
Phase: N/A
Study type: Interventional

Diabetes mellitus type 2 (T2D) is characterized by insulin resistance of liver and skeletal muscle, which is at least partly due to impaired muscle mitochondrial function. Long-term HBO therapy, as applied for treating the diabetic foot syndrome, has been shown to improve blood glucose concentrations. To study the underlying mechanisms, we want to examin the short-term effect of HBO treatment on insulin sensitivity and mitochondrial oxidative capacity and production of reactive oxygen species (ROS) in a randomized, double blinded, placebo-controlled cross-over trial.

NCT ID: NCT04218604 Completed - Atrial Fibrillation Clinical Trials

The Ablate-by-LAW Study

Start date: November 21, 2020
Phase: N/A
Study type: Interventional

Of all the determinants of lesion creation during atrial fibrillation (AF) ablation, left atrial wall thickness (LAWT), as measured with multi-detector cardiac tomography (MDCT) is one key element that has been evaluated in some retrospective analyses but is not yet used per protocol to modulate the radiofrequency delivery. Adapting ablation index (AI) to LAWT would be very useful in standardising the ablation procedure with parameters fitted to every patient, enabling the development of a personalized approach that will both: i) increase efficacy by performing transmural lesions to prevent the formation of conduction gaps in the initial lesion set, and ii) increase safety by preventing excessive RF delivery on thin wall areas related to procedural complications, such as cardiac perforation or atrio-esophageal fistula. The investigators sought to evaluate the feasibility, safety, efficacy and reproducibility of guiding AF ablation procedures with the integrated MDCT-derived LAWT information.

NCT ID: NCT04212169 Completed - Atopic Dermatitis Clinical Trials

Efficacy and Safety of MEDI3506 in Adult Subjects With Atopic Dermatitis

Start date: December 9, 2019
Phase: Phase 2
Study type: Interventional

This is a research study to determine the efficacy and safety of investigational drug MEDI3506 for the treatment of adult subjects with Atopic Dermatitis.

NCT ID: NCT04210895 Completed - Nonorganic Insomnia Clinical Trials

Efficacy of Footbaths With Ginger Powder on Subjectively Perceived Quality of Sleep

Start date: January 7, 2020
Phase: N/A
Study type: Interventional

A randomized, controlled trial to explore whether warm footbaths with added ginger powder can improve the sleep quality of adults with self-perceived insomnia symptoms. Participants receive daily footbaths either with warm water alone or with added ginger powder over a period of 2 weeks.

NCT ID: NCT04210258 Completed - Clinical trials for Facial Volume Enhancement

Post-Market Clinical Follow-up Performance and Safety Study of Etermis 3 and 4 in the Face

POMET
Start date: June 1, 2016
Phase:
Study type: Observational

To confirm the clinical performance of Etermis 3 and Etermis 4 based on the blinded investigator´s assessments on the respective Merz Aesthetics Scales from day 0 (D0) pre-injection to month 6/7 (depending on touch up) visit for nasolabial folds and marionette lines and from D0 pre-injection to month 3/4 (depending on touch up) visit for upper and lower lip fullness.

NCT ID: NCT04210245 Completed - Clinical trials for Nonalcoholic Steatohepatitis

Study of Aldafermin (NGM282) in Subjects With Compensated Cirrhosis (ALPINE 4)

Start date: March 23, 2020
Phase: Phase 2
Study type: Interventional

A multi-center evaluation of aldafermin in a randomized, double-blind, placebo-controlled study in subjects with compensated cirrhosis.